Pivotal studies of some biomedical HIV and sexually transmitted infection (STI) prevention interventions have excluded cisgender women or demonstrated low efficacy among them, limiting their prevention options relative to ...
Dec 21, 2023
0
33
The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article ...
Dec 20, 2023
0
31
Large language models (LLMs) like ChatGPT and GPT-4 have the potential to assist in clinical practice to automate administrative tasks, draft clinical notes, communicate with patients, and even support clinical decision making. ...
Dec 18, 2023
0
24
Delivering the two-dose mpox vaccine, called JYNNEOS, in smaller than the usual FDA-approved doses, and by injection between layers of the skin rather than by the standard route under the skin, produced a detectable immune ...
Dec 13, 2023
0
17
Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase 3 trial has found.
Dec 11, 2023
0
29
Researchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a commonly prescribed rheumatoid arthritis drug can suppress the progression of type 1 diabetes.
Dec 6, 2023
0
111
A new tablet treatment called divarasib has shown it is very effective in treating a challenging type of bowel (colorectal) cancer associated with the KRAS G12C mutation.
Dec 5, 2023
0
72
Doctors managing deceased organ donors routinely treat the donors' bodies with thyroid hormones in a bid to preserve heart function and increase the quantity and quality of hearts and other organs available for transplantation. ...
Nov 29, 2023
0
83
A team of investigators from Massachusetts General Hospital (MGH), Brigham and Women's Hospital (BWH), and the Broad Institute of MIT and Harvard have developed a non-invasive genetic test that can screen the blood of pregnant ...
Nov 22, 2023
0
16
A collaboration of researchers, led by UCL and Great Ormond Street Hospital, have published successful results from a Phase II clinical trial for the treatment of BRAF mutated low-grade pediatric gliomas.
Nov 21, 2023
0
11
